E3 ubiquitin ligase-mediated necroptosis: regulatory mechanisms and therapeutic implication in cancer.

Authors

Mingzhen Wei, Aiqin Sun

Published in

Molecular biology reports. Volume 53. Issue 1. Oct 10, 2026. Epub Oct 10, 2026.

Abstract

Necroptosis, a form of regulated cell death, has attracted significant attention as a potential therapeutic target for cancer. Although necroptosis is regulated at various levels, ubiquitination is key to post-translational regulation of necroptotic cell death. E3 ubiquitin ligases are the most remarkable enzymes in the ubiquitination modification, responsible for recognizing and ubiquitinating specific substrates. In this review article, we will explain how E3 ubiquitin ligases influences necroptosis, as well as to discuss what is the present state of the knowledge about the role of E3 ubiquitin ligase-mediated necroptosis in cancer development, and in response to therapy.

PMID:
42859251
Bibliographic data and abstract were imported from PubMed on 11 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.